Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
99.000 mensen gebruiken parkinsonmiddel; 64.000 voor Parkinson
apr 2026 | Bewegingsstoornissen